Armata Pharmaceuticals, Inc. — Director's Dealing 2016

Jan 20, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AmpliPhi Biosciences Corp (APHB)
CIK: 0000921114
Period of Report: 2016-01-18

Reporting Person: Martin Steven Robert (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-18	Stock Option (Right to Buy)	$2.85	A	99919	Acquired	2026-01-17	Common Stock (99919)	Direct

Footnotes

F1: 1/4th of the shares subject to the option vest on January 18, 2017. The remainder of the shares vest in equal monthly installments thereafter over the next three years.